Por favor, use este identificador para citar o enlazar este ítem:
http://www.repositorio.ufop.br/jspui/handle/123456789/4553
Título : | Bothrops moojeni myotoxin-II, a Lys49-phospholipase A2 homologue : an example of function versatility of snake venom proteins. |
Autor : | Stabeli, Rodrigo Guerino Amui, Saulo França Sant'Ana, Carolina Dalaqua Pires, Matheus Godoy Nomizo, Auro Monteiro, Marta Chagas Romão, Pedro Roosevelt Torres Cota, Renata Guerra de Sá Vieira, Carlos Alberto Giglio, José Roberto Fontes, Marcos Roberto de Mattos Soares, Andreimar Martins |
Palabras clave : | Bothrops Chemical modification Myotoxin Microbial Phospholipase |
Fecha de publicación : | 2006 |
Citación : | STABELI, R. G. et al. Bothrops moojeni myotoxin-II, a Lys49-phospholipase A2 homologue: an example of function versatility of snake venom proteins. Comparative Biochemistry and Physiology. C, Toxicology & Pharmacology, v. 142, p. 371-381, 2006. Disponível em: <http://ac.els-cdn.com/S1532045605002565/1-s2.0-S1532045605002565-main.pdf?_tid=6121ee92-9a94-11e4-b446-00000aab0f27&acdnat=1421092460_810f42242bb6648bdbafdb9fc2d3538f>. Acesso em: 08 nov. 2014. |
Resumen : | MjTX-II, a myotoxic phospholipase A2 (PLA2) homologue from Bothrops moojeni venom, was functionally and structurally characterized. The MjTX-II characterization included: (i) functional characterization (antitumoral, antimicrobial and antiparasitic effects); (ii) effects of structural modifications by 4-bromophenacyl bromide (BPB), cyanogen bromide (CNBr), acetic anhydride and 2-nitrobenzenesulphonyl fluoride (NBSF); (iii) enzymatic characterization: inhibition by low molecular weight heparin and EDTA; and (iv) molecular characterization: cDNA sequence and molecular structure prediction. The results demonstrated that MjTX-II displayed antimicrobial activity by growth inhibition against Escherichia coli and Candida albicans, antitumoral activity against Erlich ascitic tumor (EAT), human breast adenocarcinoma (SK-BR-3) and human T leukemia cells (JURKAT) and antiparasitic effects against Schistosoma mansoni and Leishmania spp., which makes MjTX-II a promising molecular model for future therapeutic applications, as well as other multifunctional homologous Lys49-PLA2s or even derived peptides. This work provides useful insights into the structural determinants of the action of Lys49-PLA2 homologues and, together with additional strategies, supports the concept of the presence of others “bioactive sites” distinct from the catalytic site in snake venom myotoxic PLA2s. |
URI : | http://www.repositorio.ufop.br/handle/123456789/4553 |
metadata.dc.identifier.doi: | https://doi.org/10.1016/j.cbpc.2005.11.020 |
ISSN : | 1532-0456 |
metadata.dc.rights.license: | O periódico Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology concede permissão para depósito deste artigo no Repositório Institucional da UFOP. Número da licença: 3547120459813. |
Aparece en las colecciones: | DECBI - Artigos publicados em periódicos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
ARTIGO_BothropsMoojeniMyotoxin.pdf | 551,49 kB | Adobe PDF | Visualizar/Abrir |
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.